Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Seal A Stock Analysis Seapeak Llc 9 Series A Preferred Holds Flat At 100 Par 20260403 Should I Buy Angeloakreit Aomr Stock Today Price At 8.60 Down 0.12 20260404 Can Cardio Diag Cdiow Stock Maintain Growth Price At 0.01 Down 4.49 20260408 What Is The Bear Case For Medicinova Mnov Stock Price At 1.48 Down 1.01 20260413 What Is The Short Interest In Renovorx Rnxt Stock Price At 0.97 Up 3.41 20260409 Janux Therapeutics JANX Stock Builds Base Mini Selloff 20260415 The real story behind CalciMedica CALC valuation Nudges Up 20260507 GRMN Garmin Ltd beats Q4 2025 EPS projections by 142 percent shares gain 116 percent on favorable investor sentiment Fox Corporation FOX Q3 Fiscal 2026 Earnings Preview Sports Momentum and Streaming Growth in Focus Why Bilibili BILI could be the anchor your portfolio needs Smart Money Active 20260511 TeraWulf WULF Stock Why Income Investors Want It Bearish Sentiment 20260420 Atlanticus ATLCL Stock Technical Trend Review Atlanticus posts 79 pct EPS beat topping analyst forecasts Sprott FUND Stock Sentiment Overview Calm 20260422 Is BEN Warrant BNAIW stock a buy or sell Dips 20260420 The biggest catalyst for DirectBooking ZDAI nobody is watching Overhead Buying 20260508 Duke Energy DUK Unveils IndustryRecord 103B 5Year Growth Capex Plan Amid AI Data Center Demand Surge and Regulatory Affordability Debates PFBC Preferred Bank posts narrow Q1 2026 EPS miss shares rise 161 percent as investors overlook the shortfall BTAI BioXcel posts narrower than expected Q4 2025 loss even as shares drop 364 percent in todays trading AbbVie Inc ABBV Former Senior Immunology RD Leader Anthony Slavin Appointed SVP of Portfolio Strategy at Infinimmune Southland Holdings SLND Falls 400 Watching 114 Support 20260515 Sangoma SANG Q1 2026 Earnings Miss by Significant Key Takeaways Cencora COR Emerges as a Healthcare Leader with Robust Fundamentals and Strategic ReRating Japans SBI and Rakuten to Launch InHouse Crypto Investment Trusts Casella CWST Crushes Q1 2026 Estimates EPS 020 Tops Views Is SR Bancorp SRBK Still a Buy After 105 Rally 20260518 Cycurion CYCU Could High Margins and Cybersecurity Demand Drive Growth in 2026 Sky SKYH Up 179 Is There More Room to Run 20260518 Columbia Bank COLB Stock Today Rallies 303 Resistance at 3108 20260520 AXT Inc Shares Surge Over 6 as Market Awaits Upcoming Business Developments EEOC Proposal to End Demographic Data Collection Raises Concerns for Workplace Discrimination Efforts Acadian Asset Management Inc AAMI Rises 2 as Stock Holds Above Key Support US Official Flags Japan as Part of FentanylSmuggling Route Enhanced Games Inside the Controversial Steroid Olympics Backed by Donald Trump Jr SP 500 MeltUp Potential Could the Index Reach 8000 or Beyond IBM Gains 27 Billion in Market Cap After US Quantum Computing Investment Announcement SP 500 Edges Higher as Tech Surge Offsets Energy Declines CSRS Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges BRC Group Holdings RILYZ Q1 2024 Earnings Bondholder Impact Amid No Revenue Visibility and Negative EPS SWKH Q3 2025 Earnings Strong EPS Beat Driven by Investment Gains and Portfolio Performance Via Transportation Inc VIA Q1 2026 Earnings EPS Beat Exceeds Estimates by 1319 MQ Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates 1RT Acquisition Corp Units ONCHU Holds Steady at 1032 Amid Quiet Trading Chicago Rivet Machine Co CVR Edges Higher as Shares Test Key Resistance Level Georgia Power Preferred Stock GPJA Edges Higher as FixedIncome Support Holds Zeta Global ZETA Surges 4 as Bullish Momentum Builds Above Key Support Oxford Lane Capital Corp OXLCG Q4 2025 Earnings Earnings Miss and Slight Stock Uptick Amid Market Caution The Battle for AI Talent MillionDollar Salaries and BillionDollar Stakes in the Race to AGI Robinhood Markets Early Exit by Graham Stephan Lessons from a Fintech Roller Coaster AEI Q1 2026 Earnings Alset Inc Reports Net Loss Amid Uncertain Market Conditions XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles